Rapid analysis of GSTM1, GSTT1 and GSTP1 polymorphisms using real-time polymerase chain reaction

被引：55
作者：
Ko, Y
Koch, B
Harth, V
Sachinidis, A
Thier, R
Vetter, H
Bolt, HM
Brüning, T
机构：
[1] Univ Dortmund, Inst Arbeitsphysiol, D-44139 Dortmund, Germany
[2] Univ Bonn, Med Poliklin, D-5300 Bonn, Germany
[3] Med Inst Umwelthyg, Abt Toxikol, Dusseldorf, Germany
来源：
PHARMACOGENETICS | 2000年 / 10卷 / 03期
关键词：
GSTM1; GSTT1; GSTP1; real-time PCR;
D O I：
10.1097/00008571-200004000-00009
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：271 / 274
页数：4
相关论文
共 11 条
  • [1] GENETIC RISK AND CARCINOGEN EXPOSURE - A COMMON INHERITED DEFECT OF THE CARCINOGEN-METABOLISM GENE GLUTATHIONE-S-TRANSFERASE M1 (GSTM1) THAT INCREASES SUSCEPTIBILITY TO BLADDER-CANCER
    BELL, DA
    TAYLOR, JA
    PAULSON, DF
    ROBERTSON, CN
    MOHLER, JL
    LUCIER, GW
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (14) : 1159 - 1164
  • [2] Simultaneous characterization of glutathione S-transfersase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks
    Chen, CL
    Liu, Q
    Relling, MV
    [J]. PHARMACOGENETICS, 1996, 6 (02): : 187 - 191
  • [3] Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer
    Harries, LW
    Stubbins, MJ
    Forman, D
    Howard, GCW
    Wolf, CR
    [J]. CARCINOGENESIS, 1997, 18 (04) : 641 - 644
  • [4] Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients
    Harris, MJ
    Coggan, M
    Langton, L
    Wilson, SR
    Board, PG
    [J]. PHARMACOGENETICS, 1998, 8 (01): : 27 - 31
  • [5] The glutathione S-Transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance
    Hayes, JD
    Pulford, DJ
    [J]. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 30 (06) : 445 - 600
  • [6] Kerb R, 1999, PHARMACOGENETICS, V9, P89
  • [7] A rare CYP19 (aromatase) variant may increase the risk of breast cancer
    Kristensen, VN
    Andersen, TI
    Lindblom, A
    Erikstein, B
    Magnus, P
    Borresen-Dale, AL
    [J]. PHARMACOGENETICS, 1998, 8 (01): : 43 - 48
  • [8] Genetic polymorphisms in human drug metabolic enzymes
    Miller, MS
    McCarver, DG
    Bell, DA
    Eaton, DL
    Goldstein, JA
    [J]. FUNDAMENTAL AND APPLIED TOXICOLOGY, 1997, 40 (01): : 1 - 14
  • [9] HUMAN GLUTATHIONE-S-TRANSFERASE-THETA (GSTT1) - CDNA CLONING AND THE CHARACTERIZATION OF A GENETIC-POLYMORPHISM
    PEMBLE, S
    SCHROEDER, KR
    SPENCER, SR
    MEYER, DJ
    HALLIER, E
    BOLT, HM
    KETTERER, B
    TAYLOR, JB
    [J]. BIOCHEMICAL JOURNAL, 1994, 300 : 271 - 276
  • [10] Rebbeck TR, 1997, CANCER EPIDEM BIOMAR, V6, P733
12